4baseCare Secures $6 Million in Series A Funding
Led by Yali Capital
New Delhi, August 12, 2023
4baseCare, a healthcare startup based in Bengaluru, has successfully raised $6 million in a Series A funding round led by Yali Capital, a leading venture capital firm focused on early-stage technology companies.
The funding will enable 4baseCare to accelerate its growth, expand its product offerings, and strengthen its team. The company provides precision oncology solutions that empower clinicians with actionable insights to guide personalized treatment decisions for cancer patients.
"We believe that precision oncology has the potential to revolutionize cancer care by enabling tailored therapies and improving patient outcomes," said Dr. Prasanna Sooriyanarayanan, CEO and Co-Founder of 4baseCare. "This funding from Yali Capital will allow us to accelerate our mission and make precision oncology accessible to more patients around the world."
Yali Capital is known for its investment in healthcare technology companies. The firm's portfolio includes several successful startups in the field, including Verana Health and Evidation Health.
"4baseCare has demonstrated a deep understanding of the challenges faced in cancer treatment," said John Liang, Partner at Yali Capital. "Their innovative solutions have the potential to improve the lives of cancer patients and their families. We are excited to partner with 4baseCare and support their vision."
This latest round of funding marks a significant milestone for 4baseCare and reflects the growing demand for precision oncology solutions in the healthcare industry.
Comments